Confirming the efficacy and broader potential of their smartphone-based diagnostic app, ResApp Health Limited (ASX: RAP) clinical data referenced in a top academic publication has validated their app’s accuracy for respiratory diagnostics. Data from their Breathe Easy adult clinical study has been published in a peer-reviewed Nature partner journal, npj Digital Medicine. The study looked
Read More
It hasn’t taken long for allied healthcare operator Healthia (ASX: HLA) to get the ball rolling in the new financial year, acquiring three new businesses in Queensland and Tasmania under their annual commitment to deploy $20m towards growth each year. The acquisitions include two optometry businesses in North Queensland and one physiotherapy clinic in Tasmania.
Read More
Since offering their last capital raise to accelerate growth, digital payments company Novatti Group (ASX: NOV) has increased its market cap by more than 200% which was one reason institutions were keen to get involved with the Aussie fintech and their latest expansion plans. The cornerstone of what will be a total $45 million raise
Read More
Despite the many advances in cancer therapy, we still haven’t quite hit the nail on the head, with cancer still responsible for 12% of all deaths worldwide each year. The advancement of cancer therapies and the growing body of research is impressive to say the least, yet cancer patients of today do not fare much
Read More
With ever increasing bodies of medical research and demand for early disease detection climbing, it’s high time that we rethink diagnostic testing. The trend of having to wait three days to see if your pee is free of nasties is fraught with administration challenges and can delay treatment. Spend time in any medical establishment and
Read More
Having successfully developed a number of drugs through to regulatory approval and commercial sales, Pharmaxis (ASX: PXS) is set to realise a $2 million windfall with the sale of their Australian distribution rights, a move that will focus the Company’s efforts towards their advancing cancer treatment clinical trials. The deal will send the distribution rights
Read More
Ahh the pap smear. The daunting, uncomfortable and downright annoying process of having a cervical swab taken to be tested for cancerous or precancerous cells, only to be repeated in 3-5 years time. Despite being an important aspect of women’s health – COVID-19, uncomfortable gyno appointments, and misinformation means that booking in for that test
Read More
It seems that Harris Technology (ASX: HT8) has the Midas Touch because everything they’ve been a part of recently has turned to gold. Fresh off a record Prime Day in sales on Amazon, Harris Technology has reported a bumper result on eBay to generate $1.1 million in sales, their first 7-figure month. Impressively, the online
Read More
Addressing a chronically overlooked group in the nutritional supplement space is working out well for Nutritional Growth Solutions (ASX: NGS). The supplement company is focused on improving the health of children aged 3-12 years old who do not meet the criteria for growth hormone therapy. A group that has been long overlooked in terms of
Read More
As someone who was 9 years old once upon a time and desperate for a Gecko, Firefly or TicTalk, I’m pretty sure that Spacetalk’s (ASX: SPA) Adventurer would have sent my primary school self a bit nuts. Like a kid-on-red-cordial nuts. The kids with the cool spy girl looking devices were the envy of my
Read More
